Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl)ethoxy]phenoxy}propionic acids:: A new class of dual PPARα/γ agonists

被引：76

作者：

Brooks, DA ^{[1
]}

Etgen, GJ

Rito, CJ

Shuker, AJ

Dominianni, SJ

Warshawsky, AM

Ardecky, R

Paterniti, JR

Tyhonas, J

Karanewsky, DS

Kauffman, RF

Broderick, CL

Oldham, BA

Montrose-Rafizadeh, C

Winneroski, LL

Faul, MM

McCarthy, JR

机构：

[1] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

[2] Ligand Pharmaceut Inc, San Diego, CA 92121 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2001年 / 44卷 / 13期

关键词：

D O I：

10.1021/jm0155188

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Propionic acid derivative 8, which was designed and synthesized based on putative pharmacophores of known PPAR gamma- and PPAR alpha -selective compounds, exhibits potent dual PPAR alpha/gamma agonist activity as demonstrated by in vitro binding and dose overlap in the newly introduced EOB mouse model for glucose lowering and lipid/cholesterol homeostasis.

引用

页码：2061 / 2064

页数：4

共 24 条

[1] Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO
[2] 2-I
[3] Auwerx J, 1999, INT CONGR SER, V1177, P167
[4] Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
Berthou, L
Duverger, N
Emmanuel, F
Langouet, S
Auwerx, J
Guillouzo, A
Fruchart, JC
Rubin, E
Denefle, P
Staels, B
Branellec, D
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2408 - 2416
[5] A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
Chawla, A
Boisvert, WA
Lee, CH
Laffitte, BA
Barak, Y
Joseph, SB
Liao, D
Nagy, L
Edwards, PA
Curtiss, LK
Evans, RM
Tontonoz, P
[J]. MOLECULAR CELL, 2001, 7 (01) : 161 - 171
[6] Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice - Pleiotropic effects on CD36 expression and HDL
Chen, Z
Ishibashi, S
Perrey, S
Osuga, J
Gotoda, T
Kitamine, T
Tamura, Y
Okazaki, H
Yahagi, N
Iizuka, Y
Shionoiri, F
Ohashi, K
Harada, K
Shimano, H
Nagai, R
Yamada, N
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) : 372 - 377
[7] Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice
Collins, AR
Meehan, WP
Kintscher, U
Jackson, S
Wakino, S
Noh, G
Palinski, W
Hsueh, WA
Law, RE
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) : 365 - 371
[8] Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
Fruchart, JC
Duriez, P
Staels, B
[J]. CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) : 245 - 257
[9] GOTO Y, 1971, CHEM PHARM BULL, V19, P2050
[10] Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity
Guerre-Millo, M
Gervois, P
Raspé, E
Madsen, L
Poulain, P
Derudas, B
Herbert, JM
Winegar, DA
Willson, TM
Fruchart, JC
Berge, RK
Staels, B
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) : 16638 - 16642

← 1 2 3 →